Huapont Life Sciences Co.,Ltd. Statistics

Total Valuation

Huapont Life Sciences Co.,Ltd. has a market cap or net worth of CNY 9.69 billion. The enterprise value is 21.19 billion.

Market Cap	9.69B
Enterprise Value	21.19B

Important Dates

The next estimated earnings date is Sunday, April 27, 2025.

Earnings Date	Apr 27, 2025
Ex-Dividend Date	n/a

Share Statistics

Huapont Life Sciences Co.,Ltd. has 1.97 billion shares outstanding. The number of shares has decreased by -0.20% in one year.

Current Share Class	n/a
Shares Outstanding	1.97B
Shares Change (YoY)	-0.20%
Shares Change (QoQ)	-0.09%
Owned by Insiders (%)	16.49%
Owned by Institutions (%)	4.79%
Float	1.26B

Valuation Ratios

The trailing PE ratio is 38.94.

PE Ratio	38.94
Forward PE	n/a
PS Ratio	0.83
PB Ratio	0.96
P/TBV Ratio	1.66
P/FCF Ratio	24.64
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.12, with an EV/FCF ratio of 53.88.

EV / Earnings	85.03
EV / Sales	1.82
EV / EBITDA	10.12
EV / EBIT	18.45
EV / FCF	53.88

Financial Position

The company has a current ratio of 1.11, with a Debt / Equity ratio of 0.57.

Current Ratio	1.11
Quick Ratio	0.74
Debt / Equity	0.57
Debt / EBITDA	4.49
Debt / FCF	23.88
Interest Coverage	3.21

Financial Efficiency

Return on equity (ROE) is 2.33% and return on invested capital (ROIC) is 2.82%.

Return on Equity (ROE)	2.33%
Return on Assets (ROA)	2.34%
Return on Capital (ROIC)	2.82%
Revenue Per Employee	926,181
Profits Per Employee	19,807
Employee Count	12,580
Asset Turnover	0.38
Inventory Turnover	3.02

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1.46% in the last 52 weeks. The beta is 0.48, so Huapont Life Sciences Co.,Ltd.'s price volatility has been lower than the market average.

Beta (5Y)	0.48
52-Week Price Change	+1.46%
50-Day Moving Average	4.67
200-Day Moving Average	4.35
Relative Strength Index (RSI)	62.05
Average Volume (20 Days)	20,362,556

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Huapont Life Sciences Co.,Ltd. had revenue of CNY 11.65 billion and earned 249.17 million in profits. Earnings per share was 0.13.

Revenue	11.65B
Gross Profit	4.09B
Operating Income	1.15B
Pretax Income	559.61M
Net Income	249.17M
EBITDA	2.06B
EBIT	1.15B
Earnings Per Share (EPS)	0.13

Full Income Statement

Balance Sheet

The company has 4.24 billion in cash and 9.39 billion in debt, giving a net cash position of -5.15 billion or -2.61 per share.

Cash & Cash Equivalents	4.24B
Total Debt	9.39B
Net Cash	-5.15B
Net Cash Per Share	-2.61
Equity (Book Value)	16.45B
Book Value Per Share	5.12
Working Capital	1.20B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.50 billion and capital expenditures -1.11 billion, giving a free cash flow of 393.20 million.

Operating Cash Flow	1.50B
Capital Expenditures	-1.11B
Free Cash Flow	393.20M
FCF Per Share	0.20

Full Cash Flow Statement

Margins

Gross margin is 35.08%, with operating and profit margins of 9.86% and 2.14%.

Gross Margin	35.08%
Operating Margin	9.86%
Pretax Margin	4.80%
Profit Margin	2.14%
EBITDA Margin	17.68%
EBIT Margin	9.86%
FCF Margin	3.37%

Dividends & Yields

This stock pays an annual dividend of 0.22, which amounts to a dividend yield of 4.52%.

Dividend Per Share	0.22
Dividend Yield	4.52%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	304.79%
Buyback Yield	0.20%
Shareholder Yield	4.71%
Earnings Yield	2.57%
FCF Yield	4.06%

Dividend Details

Stock Splits

The last stock split was on May 27, 2015. It was a forward split with a ratio of 2.5.

Last Split Date	May 27, 2015
Split Type	Forward
Split Ratio	2.5

Scores

Huapont Life Sciences Co.,Ltd. has an Altman Z-Score of 1.03. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.03
Piotroski F-Score	n/a